Your browser doesn't support javascript.
loading
CanVasc recommendations for the management of antineutrophil cytoplasm antibody (ANCA)-associated vasculitides - Executive summary.
McGeoch, Lucy; Twilt, Marinka; Famorca, Leilani; Bakowsky, Volodko; Barra, Lillian; Benseler, Susan; Cabral, David A; Carette, Simon; Cox, Gerald P; Dhindsa, Navjot; Dipchand, Christine; Fifi-Mah, Aurore; Goulet, Michele; Khalidi, Nader; Khraishi, Majed M; Liang, Patrick; Milman, Nataliya; Pineau, Christian A; Reich, Heather; Samadi, Nooshin; Shojania, Kam; Taylor-Gjevre, Regina; Towheed, Tanveer E; Trudeau, Judith; Walsh, Michael; Yacyshyn, Elaine; Pagnoux, Christian.
Afiliação
  • McGeoch L; Department of Rheumatology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario Canada ; Current address: Centre for Rheumatic Diseases, Glasgow Royal Infirmary, Glasgow, UK.
  • Twilt M; Division of Pediatric Rheumatology, Alberta Children's Hospital, University of Calgary, Calgary, Alberta Canada.
  • Famorca L; Division of Rheumatology, McMaster University, Hamilton and Langs Community Centre, Cambridge, Canada.
  • Bakowsky V; Division of Rheumatology, QEII Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia Canada.
  • Barra L; Division of Rheumatology, St. Joseph's Health Care, London, Ontario Canada.
  • Benseler S; Division of Pediatric Rheumatology, Alberta Children's Hospital, University of Calgary, Calgary, Alberta Canada.
  • Cabral DA; Division of Pediatric Rheumatology, BC Children's Hospital and University of British Columbia, Vancouver, British Columbia Canada.
  • Carette S; Department of Rheumatology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario Canada.
  • Cox GP; Division of Respirology, McMaster University, St. Joseph's Healthcare, Hamilton, Ontario Canada.
  • Dhindsa N; Division of Nephrology, Dalhousie University, Halifax, Nova Scotia.
  • Dipchand C; Section of Rheumatology, University of Manitoba, Arthritis Centre, Winnipeg, Manitoba Canada.
  • Fifi-Mah A; University of Calgary, Calgary, Alberta Canada.
  • Goulet M; Division of Internal Medicine, Hôpital Du Sacré-Coeur, Montréal, Québec Canada.
  • Khalidi N; Division of Rheumatology, McMaster University, Hamilton, Ontario Canada.
  • Khraishi MM; Division of Rheumatology, Memorial University of Newfoundland, Nexus Clinical Research, St. Johns, Newfoundland Canada.
  • Liang P; Division of Rheumatology, Centre Hospitalier Universitaire de Sherbrooke, Québec, Canada.
  • Milman N; Division of Rheumatology, the Ottawa Hospital/University of Ottawa, Ottawa, Ontario Canada.
  • Pineau CA; Division of Rheumatology, Lupus and Vasculitis Clinic, McGill University, Montréal, Québec Canada.
  • Reich H; Gabor Zellerman Chair in Nephrology Research of Toronto, Division of Nephrology, University Health Network, Toronto, Ontario Canada.
  • Samadi N; Division of Rheumatology and the Arthritis Program Research Group in Newmarket, Newmarket, Ontario Canada.
  • Shojania K; Division of Rheumatology, Arthritis Research Canada, University of British Columbia, Vancouver, British Columbia Canada.
  • Taylor-Gjevre R; Division of Rheumatology, University of Saskatchewan, Saskatoon, Saskatchewan Canada.
  • Towheed TE; Department of Medicine, Queen's University, Kingston, Ontario Canada.
  • Trudeau J; Division of Rheumatology, CHAU Hôtel-Dieu de Lévis, Université Laval, Québec, Canada.
  • Walsh M; Department of Medicine and Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario Canada.
  • Yacyshyn E; Division of Rheumatology, University of Alberta, Edmonton, Alberta.
  • Pagnoux C; Department of Rheumatology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario Canada.
Article em En | MEDLINE | ID: mdl-26557369
ABSTRACT
The Canadian Vasculitis research network (CanVasc) is composed of physicians from different medical specialties, including rheumatology and nephrology and researchers with expertise in vasculitis. One of its aims was to develop recommendations for the diagnosis and management of antineutrophil cytoplasm antibody (ANCA)-associated vasculitides in Canada. This executive summary features the 19 recommendations and 17 statements addressing general AAV diagnosis and management, developed by CanVasc group based on a synthesis of existing international guidelines, other published supporting evidence and expert consensus considering the Canadian healthcare context.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Risk_factors_studies Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Risk_factors_studies Idioma: En Ano de publicação: 2015 Tipo de documento: Article